Circulating Tumour DNA and Its Prognostic Role in Management of Muscle Invasive Bladder Cancer: A Narrative Review of the Literature

Current management of non-metastatic muscle invasive bladder cancer (MIBC) includes radical cystectomy and cisplatin-based neoadjuvant chemotherapy (NAC), offers a 5-year survival rate of approximately 50% and is associated with significant toxicities. A growing body of evidence supports the role of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Konstantinos Kapriniotis, Lazaros Tzelves, Lazaros Lazarou, Maria Mitsogianni, Iraklis Mitsogiannis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-04-01
coleção:	Biomedicines
Assuntos:	circulating tumour deoxyribonucleic acid (DNA) ctDNA liquid biopsies bladder cancer muscle invasive bladder cancer (MIBC)
Acesso em linha:	https://www.mdpi.com/2227-9059/12/4/921
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!